As part of the 2000 and 2002 Spending Review, the ESRC received 10 million to fund initiatives looking at the social and economic context of genomics.

The Centre for Economic and Social Aspects of Genomics (CESAGen), which will receive around 8 million of funding over five years, is a Cardiff-Lancaster collaboration led by Professor Ruth Chadwick, in which researchers from the social sciences and the humanities work closely with those in the natural and medical sciences to address the social, economic and policy aspects of development in genomics. Key challenges in the next few years will include addressing the social dimensions of the applications of genomics in health service delivery, with reference to both common and rare diseases; and in areas such as food and nutrition, behaviour and criminal responsibility, and human enhancement.

EGENIS, the ESRC Centre for Genomics in Society, based at Exeter will receive almost 4 million over the five years. EGENIS, headed by Professor John Dupr?©, is an interdisciplinary research centre looking at the social implications of contemporary genetic science especially in areas such as nutrigenomics, systems biology and gene therapy which have the potential to become highly contentious in society.

Innogen, a collaboration between Edinburgh University and the Open University, is the ESRC Centre for Social and Economic Research on Innovation in Genomics and will receive further funding of around 5 million over five years. Innogen's research programme brings together social, medical and natural scientists to work on evolution of the new life science economy and the governance of innovation in the life sciences, in partnership with industry and private interest groups; policy makers and regulators; citizens and public interest groups, in genomics innovation. Taking over from Professor Joyce Tait, Innogen will also welcome a new Centre Director, Professor David Wield, from October 2007.

Commenting on the announcements, Adrian Alsop, Director for Research, Training and Development for the ESRC, said, "We are delighted to announce this second phase of funding for our genomics research centres. The unique ESRC Genomics Network allows us to work in collaboration with medical and natural scientists in order to build understanding in this area. The Network has quickly established a world leading presence for the UK in this important area. Insights from social science explain how genomic technologies can benefit our health service and realise the potential benefits that they bring to developing countries."

esrcsocietytoday.ac